These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2940855)

  • 1. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
    Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    Am J Cardiol; 1986 Jul; 58(1):110-6. PubMed ID: 2942027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Eichhorn EJ; Konstam MA; Weiland DS; Roberts DJ; Martin TT; Stransky NB; Salem DN
    Am J Cardiol; 1987 Dec; 60(16):1329-33. PubMed ID: 3687783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
    Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
    Kereiakes DJ; Viquerat C; Lanzer P; Botvinick EH; Spangenberg R; Buckingham M; Parmley WW; Chatterjee K
    Am Heart J; 1984 Nov; 108(5):1278-84. PubMed ID: 6238512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH; Raw K; Patel J; Mitha A; Sareli P
    Am J Cardiol; 1990 Nov; 66(15):1107-12. PubMed ID: 2220638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Weber KT; Janicki JS; Jain MC
    Am J Cardiol; 1986 Sep; 58(7):589-95. PubMed ID: 2944369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
    Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.